(Q81262362)

English

Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children's oncology group

scientific article published on 01 November 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16184615%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children's oncology group (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16184615%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

author name string

Michael J Borowitz

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16184615%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

D Jeanette Pullen

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16184615%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Naomi Winick

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16184615%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Paul L Martin

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16184615%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

W Paul Bowman

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16184615%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Bruce Camitta

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16184615%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 November 2005

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16184615%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Cytometry Part B: Clinical Cytometry

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16184615%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

68

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16184615%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16184615%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

18-24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16184615%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20071

7 January 2021

based on heuristic

inferred from DOI database lookup

Flow cytometric follow-up of minimal residual disease in bone marrow gives prognostic information in children with acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20071

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20071

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20071

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome prediction by immunophenotypic minimal residual disease detection in adult T-cell acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20071

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20071

7 January 2021

based on heuristic

inferred from DOI database lookup

Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20071

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20071

7 January 2021

based on heuristic

inferred from DOI database lookup

Triple immunofluorescence staining for prediction of relapse in childhood precursor B acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20071

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of minimal residual disease in acute lymphoblastic leukemia: the St Jude experience

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20071

7 January 2021

based on heuristic

inferred from DOI database lookup

BIOMED-1 concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20071

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute lymphoblastic leukemia (ALL): detection of minimal residual disease (MRD) at flow cytometry

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20071

7 January 2021

based on heuristic

inferred from DOI database lookup

A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: implications for residual disease detection

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20071

7 January 2021

based on heuristic

inferred from DOI database lookup

MRD at the end of induction therapy in childhood acute lymphoblastic leukemia: outcome prediction strongly depends on the therapeutic regimen

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20071

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunophenotype of adult and childhood acute lymphoblastic leukemia: changes at first relapse and clinico-prognostic implications

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20071

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow and extramedullary variations of cell membrane antigen expression in childhood lymphoid neoplasias at relapse

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20071

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute lymphoblastic leukaemia associated antigen. III ALterations in expression during treatment and in relapse

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20071

7 January 2021

based on heuristic

inferred from DOI database lookup

Adult acute lymphoblastic leukemia at relapse. Cytogenetic, immunophenotypic, and molecular changes

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20071

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunophenotypic and cytogenetic changes in acute leukaemia at relapse

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20071

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CYTO.B.20071

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16184615%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16184615%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81262362&oldid=2055614155"